Prevention and management of osteoporosis.
Osteoporotic fractures are a growing public health issue. Prevention and management of osteoporosis are becoming increasing concerns especially as the number of individuals reaching old age continues to grow, euphemistically "as the baby boomers come of age." Identification of those individuals who are at an increased risk for fracture is important for planning and implementing proper prevention and management strategies. Although diagnostic tools are available for identifying decreased bone density and effective therapies exist for treatment of existing disease, clinical guidelines based on cost-effective approaches are still needed to more accurately identify which patients would benefit from early intervention (either prevention or treatment).
Simon
James A
JA
Department of Ob/Gyn, The George Washington University School of Medicine, Washington, DC, USA.
Mack
Carol J
CJ
D002116:Calcitonin / Q000494:pharmacology / Q000627:therapeutic use; D004164:Diphosphonates / Q000494:pharmacology / Q000627:therapeutic use; D004967:Estrogens / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000628:therapy*; D010281:Parathyroid Hormone / Q000494:pharmacology / Q000627:therapeutic use; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology / Q000627:therapeutic use
D004164:Diphosphonates; D004967:Estrogens; D010281:Parathyroid Hormone; D020845:Selective Estrogen Receptor Modulators; D002116:Calcitonin